Vitaspring Biomedical Co. Ltd. (VSBC): EBITDA

Operating income plus depreciation and amortization for the same annual period and currency, computed by TickerFacts from the filed figures. Not the company's adjusted EBITDA; a year without both inputs is left out.

-$670.0K
Year ended 2025-01-31
2024-01-31: -$1.10M2025-01-31: -$670.0K-$670.0K
2024-01-31 EBITDA (USD) 2025-01-31
Period endedEBITDAChange YoYSource filing
2025-01-31-$670.0Kn/m2026-06-17, From 2024-02-01
2024-01-31-$1.10Mn/a2026-06-08, From 2023-02-01